A 2024 paper in Physiology & Behavior characterised that ipamorelin and the related GHSR-1a agonist anamorelin inhibited cisplatin-induced weight loss in ferrets, framing one route by which the GHSR-1a agonist class engages cachexia research (PMID 39043357)
More intensive skin brightening protocols may suggest dosages between 1,500 to 4,000 mg once or twice a week, but these higher doses require close medical guidance
This includes detailed medical history, physical examination, and essential laboratory work
Solo investigacin
found that ipamorelin can stimulate GH release in animals (swine and rats) to an extent comparable with GHRP-6 [3]
The cjc and ipa mix boosts natural GH production, keeps pulsatile patterns, preserves the bodys control mechanisms, has fewer side effects at equivalent GH rise, and is more cost-effective